does glp 1 do more than suppress appetite The GLP-1 revolution: What UAB researchers are discovering about how these drugs work Common Mistakes Patients Make When

GLP-1 weight loss drugs are transforming obesity treatment

Baseline labs help identify conditions like insulin resistance, liver dysfunction, and kidney impairment, which influence treatment safety and dosing.

Designed to support appetite management and fullness

Semaglutide (Wegovy) reduced pain and improved physical function in patients with obesity and knee osteoarthritis, a randomized trial showed.Among 407 adults, the mean change in the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score from baseline to week 68 was -41.7 points in the semaglutide group and -27.5 points in the placebo group (P

As dietitians, were navigating big questions: - When GLP-1 medications reduce appetite significantly, what are the most effective strategies to help patients prioritise nutrition, not just weight loss

We have discussed this before, but now at the #TippingPointInObesityCare we have to take action to change it